DAY 1 – 5 December, 2022
8:30 > 9:00 a.m
Welcome participants / Coffee
9:00 > 9:30 a.m
OPENING SESSION
9:30 > 10:15 a.m
KEYNOTE PRESENTATION
E-Cigarettes: Key Policy and Research Questions
> Mitch Zeller, J.D, Retired Director, U.S. Food and Drug Administration, Center for Tobacco Products
10:15 > 11:30a.m
PLENARY SESSION
E-Cigarette research challenges
Chair: Karl Erik Lund, Norwegian Institute of Public Health
> Jamie Hartmann-Boyce, University of Oxford
> Paraskevi Katsaounou, Medical School of the National and Kapodistrian University of Athens
> Ute Mons, University of Cologne and the German Cancer Research Center (DKFZ)
> Caitlin Notley, University of East Anglia
> Lion Shahab, University College London
11:30 > 11:45 a.m
Coffee break
11:45 > 12:45 a.m
PARALLEL SESSION N°1
SYMPOSIUM 1
Chair: Martin Dockrell
Effect of Electronic Cigarettes on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial
> Jonathan Foulds
Association of Electronic Cigarette Use With Discontinuation of Cigarette Smoking Among Adult Smokers Who Were Initially Never Planning to Quit
> Karin Kasza
Do the associations between the use of electronic cigarettes and smoking reduction or cessation attempt persist after several years of use? Longitudinal analyses in smokers of the CONSTANCES cohort
> Guillaume Airagnes
SYMPOSIUM 2
Chair: Jérémie Achille
Regulation of electronic cigarettes and novel tobacco products in EU Member States
> Olga Caratier
To evaluate the use, abuse potential and health risks of novel tobacco products and e-cigarettes
> Jérémie Achille
Investigations regarding e-cigarettes and novel tobacco products awareness, use and perceptions
> Silvano Gallus
WORKSHOP 1
Chair: Jérémie Pourchez
Correlates of perceived addiction and product addictiveness of e-cigarettes – the EValuation of the Addictive Potential of E-cigarettes (EVAPE) project
> Valérie Lohner
Self-reported signs of Substance Use Disorder in e-cigarette online forums
> Marike Andreas
Sensory appeal and puffing intensity of e-cigarette use: influence of nicotine salts versus free-base nicotine in e-liquids
> Charlotte Pauwels
Youth’s views and experimentation with disposable e-cigarettes: using focus groups
> Marissa Smith
12:45 > 2:00 p.m
Lunch
POSTER SESSION 1
12:50-1:10: Marketing and young people
Chair : Florence Cousson-Gélie, University of Montpellier
1:00-1:30: Smokers, vapers, dual users
Chair : Christophe Tzourio, University of Bordeaux
2:00 > 2:45 p.m
KEYNOTE PRESENTATION
E-cigarette and tobacco use: friend or foe?
> Maria Melchior, French National Institute of Health and Medical Research (INSERM)
2:45 > 4:00 p.m
PARALLEL SESSION N°2
WORKSHOP 2
Chair: Paraskevi Katsaounou
Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
> David T. Levy
Electronic Nicotine Delivery Systems (ENDS) use during a five-year period is not associated with self-reported chronic obstructive pulmonary disease (COPD) after adjustment of cigarette smoking history: A longitudinal analysis of PATH data.
> Rafael Meza
Unintended consequences of vaping: injuries from poisonings and explosions
> Debbie Robson
WORKSHOP 3
Chair: Véronique Régnier
European adult smokers’ perceptions of the harmfulness of e-cigarettes relative to combustible cigarettes: Findings from the France and EUREST-PLUS ITC Surveys
> Geoffrey Fong
An appeal that does not last: French youths’ attitude toward e-cigarette. Results from the ARAMIS study (2014, 2019)
> Marc-Antoine Douchet
Electronic cigarette packaging in context: an exploratory study
> Frances Thirlway
WORKSHOP 4
Chair: Caitlin Notley
Using ecological momentary assessment via text messaging to measure cigarette and e-cigarette use patterns
> Elizabeth Stevens
Tracking via Repeated Assessment of Joint E-Cigarette and Tobacco use (TRAJECT): Descriptive and qualitative findings exploring trajectories of dual e-cigarette and tobacco use
> Emma Ward
Adolescents (15-18 years old) in the narratives of experimentation/use trajectories: structuring factors and their effects on transitions between vaping and smoking
> Lara Leclerc
The impact of electronic cigarette and heated tobacco product on conventional smoking: an Italian prospective cohort study form Italy conducted during the COVID-19 pandemic
> Silvano Gallus
4:00 > 4:15 p.m
Coffee break
4:15 > 5:00 p.m
KEYNOTE PRESENTATION
Flavours and flavourings in e-cigarettes: prevalence, perception and regulation
> Reinskje Talhout, National Institute for Public Health and the Environment (RIVM)
5:00 > 5:45 p.m
PLENARY SESSION
Lessons from workshops
Chair: Marcus Munafo, University of Bristol
> Jamie Hartmann-Boyce, University of Oxford
> Paraskevi Katsaounou, Medical School of the National and Kapodistrian University of Athens
> Caitlin Notley, University of East Anglia
> Jérémie Pourchez, Ecole Nationale Supérieure des mines
> Veronique Régnier, University of Saint-Etienne
6:00 > 7:00 p.m
Cocktail
DAY 2 – 6 December, 2022
8:45 > 9:15 a.m
Welcome participants / Coffee
9:15 > 10:00 a.m
KEYNOTE PRESENTATION
Vaping and the vulnerable
> Ann McNeill, King’s College London
10:00 > 10:45 a.m
KEYNOTE PRESENTATION
The ITC Nicotine Product Conceptual Model: A Framework for Understanding Transitions Among
Cigarettes, E-Cigarettes, and Other Nicotine Products and the Impact of Policies on Those Transitions
> Geoffrey Fong, University of Waterloo
10:45 > 11:30 a.m
Coffee break
POSTER SESSION 2
Trajectory and prevalence: around the world
Chair: Silvano Gallus, Mario Negri Institute
11:30 > 12:45 p.m
PARALLEL SESSION N°3
WORKSHOP 5
Chair : Reinskje Talhout
Comparison of chemical composition and toxicity effects of emissions from electronic cigarettes, heated tobacco products and tobacco cigarettes in human bronchial epithelial cells
> Gianni Zarcone
Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review
> David T. Levy
> Nargiz Travis
Metabolomic strategy to identify markers of exposure and toxicity of electronic cigarettes, heated tobacco products and tobacco cigarettes,
> Marie Lenski
WORKSHOP 6
Chair: Lion Shahab
An online randomised optimisation experiment to identify effective intervention components to support smokers to use e-cigarettes in a quit attempt
> Lynne Dawkins
Effect of Tobacco Cessation Aids on Smoking Cessation and Duration of Abstinence: a French Population-Based Study
> Mathilde Fekom
E-cigarettes for smoking cessation: the latest Cochrane living systematic review evidence
> Ailsa Butler & Jamie Hartmann-Boyce
Use of pod device e-cigarettes in the Cessation of Smoking Trial in the Emergency Department
> Ian Pope
SYMPOSIUM 3
Chairs: François Alla and Ivan Berlin
Are ENDS an aid to quit smoking and what can be its role in a global smoking cessation strategy? Can these products be considered as risk reduction tools?
> Ivan Berlin
Recommendations of the French High Council of Public Health, France (HCPH) on the benefit/risk profile of electronic cigarettes among specific groups of smokers
> Anne-Laurence Le Faou
Is there a risk that ENDS encourage a renormalization of tobacco consumption in France?
> Karine Gallopel-Morvan
Is ENDS use a gateway for becoming a smoker among youths?
> François Alla
12:45 > 2:15 p.m
Lunch
POSTER SESSION 3
12:45-1:45 : Addictiveness and toxicity
Chair: Benoît Labarbe, French Agency for Food, Environmental and Occupational Health & Safety (ANSES)
1:30-2:10: Smoking cessation:what interventions?
Chair: Anne-Fleur Guillemin, French National Cancer Institute
2:15 > 3:30 p.m
PARALLEL SESSION N°4
WORKSHOP 7
Chair: Ute Mons
Prevalence of vaping in France in 2021: results from the Santé publique France Health Barometer
> Anne Pasquereau
E-cigarette Use and its Associated Factors Among a Sample of Romanian Pregnant Smokers and Ex-smokers
> Rana Jaber
Tobacco and e-cigarette use among French adolescents. Prevalence, trends and associations: where we are in 2022?
> Eric Janssen
Birth-cohort patterns of e-cigarette use among adolescents in the US
> Rafael Meza
SYMPOSIUM 4
Chair: Ann McNeill
Methods and health risks of nicotine and flavourings
> Debbie Robson
Biomarkers of exposure
> Eve Taylor
Cancer, respiratory and cardiovascular diseases (CVD)
> Leonie Brose
Overview of methodological limitations when assessing vaping effects on health biomarkers
> Erikas Simonavičius
3:30 > 3:45 p.m
Coffee break
3:45 > 4:30 p.m
KEYNOTE PRESENTATION
From Lab Bench to Population Impact: Investigating Health Effects of E-cigarettes
> Maciej Goniewicz, Department of Health Behavior Roswell Park Comprehensive Cancer Center
4:30 > 5:15 p.m
PLENARY SESSION
Lessons from workshops
Co-chairs: Anbu Paramasivam, Cancer Research UK & Martin Dockrell, Office for Health Improvement and Disparities
> Ute Mons, University of Cologne and the German Cancer Research Center (DKFZ)
> Lion Shahab, University College London
> Reinskje Talhout, National Institute for Public Health and the Environment (RIVM)
5:15 > 5:45 p.m
Closing ceremony